By VC News Daily
BOSTON, MA, Circe, a startup commercializing a novel bioproduction technology, has raised more than $8 million.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Circe, a startup developed at the Institute and spun out of Harvard, has signed a worldwide, exclusive licensing agreement coordinated by Harvard’s Office of Technology Development (OTD) to commercialize a novel bioproduction technology that could significantly reduce the carbon emissions of industries from food to aviation fuel.
Circe has raised more than $8 million to date from investors including Regen Ventures, Undeterred Capital, Ponderosa Ventures, Bee Partners, and Elementum Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our about page.